PAS
KYNB

Point72 Asia (Singapore)’s Kyntra Bio KYNB Stock Holding History

Point72 Asia (Singapore)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,381
Closed -$18.3K – 984
2024
Q4 		$18.3K Sell
1,381
-158
-10% -$1.47K ﹤0.01% 684
2024
Q3 		$15.4K Sell
1,539
-4,276
-74% -$64.5K ﹤0.01% 844
2024
Q2 		$130K Buy
+5,815
New +$180K 0.03% 412

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asia (Singapore)'s KYNB Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 1,381 shares — an estimated $18.3K sold.

Point72 Asia (Singapore) first reported a position in KYNB in Q2 2024 and held it in 3 quarters. The position peaked at $130K in Q2 2024. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 1,381 Kyntra Bio shares in Q1 2025, an estimated $18.3K.
  • Point72 Asia (Singapore) first reported a position in Kyntra Bio in Q2 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Kyntra Bio position peaked at $130K in Q2 2024.
  • 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.